Trafford Clarke's most recent trade in Traws Pharma Inc. was a trade of 24,629 Stock Option (right to purchase) done . Disclosure was reported to the exchange on Dec. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 24,629 | 24,629 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 6,157 | 6,157 (0%) | 0% | 0 | Common Stock | |
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2025 | 11,530 | 11,530 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2025 | 23,000 | 23,000 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 100,000 | 100,000 | - | - | Stock Option (right to purchase) |